Development Technologies Corp.
Not enough financial coverage to compute a composite score for DVTC. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.pegasusbiosciences.com
Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases.
- CEO
- Daniel Kesonen
- IPO
- 1997
- HQ
- Palm Beach Gardens, FL, US
Price Chart
Performance & Tape
- 52W High
- $20.00
- 52W Low
- $2.02
- 50D MA
- $5.00
- 200D MA
- $5.00
- Beta
- 3.59
- Avg Volume
- 39.72
Get TickerSpark's AI analysis on DVTC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our DVTC Coverage
We haven't published any research on DVTC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DVTC Report →